Education
About Us
Working with TipRanks
Follow Us
Top UK Pharma & Biotech Shares
Comparison Results
Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | Healthcare | 14346.00 p | 364.67K | £223.35B | 28.13 | 1.64% | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | 1990.02 p | 1.42M | £80.59B | 12.93 | 3.06% | Hold | xxxxxxxxxxxxx | |||
 | Healthcare | 1272.00 p | 303.36K | £2.81B | 11.21 | 4.93% | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | 219.00 p | 130.00 | £1.87B | 4.97 | ― | Strong Buy | xxxxxxxxxxxxx | |||
 | ― | ― | ― | ― | ― | ― | ― | xxxxxxxxxxxxx |
Top 10 Popular Investment Themes
Popular Stock Pairs
Performance Comparison
GB:AZN
AstraZeneca
14,402.00
2,758.92
23.70%
GB:GSK
GlaxoSmithKline
2,013.00
541.30
36.78%
GB:HIK
Hikma Pharmaceuticals
1,288.00
-703.75
-35.33%
GB:HCM
HUTCHMED (China)
214.00
-16.00
-6.96%
GB:DPH
Dechra Pharmaceuticals
―
―
―
Pharma & Biotech Latest News
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
Apr 29, 2026TBA
£223.35B
188.47 p
1.11T
0.69
28.13
Apr 29, 2026Before Open
£80.59B
43.00 p
765.66B
0.11
12.93
Aug 6, 2026TBA
£2.81B
―
―
1.27
11.21
Aug 3, 2026TBA
£1.87B
0.90 p
23.40B
<0.01
4.97
―
―
―
―
―
―
Compare Stocks Side-by-SideOur stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.Key Features of Our Stock Comparison
Comprehensive Analysis: Compare up to 10 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison ToolSimply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 10 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock ComparisonsInvestors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
Pharma & Biotech - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
HUTCHMED (China) - Strong Buy, based on 9 analyst ratings, 8 Buy, 0 Hold, and 1 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 14,346.00 p, and its average 12-month price target is 15,989.52 p.
GlaxoSmithKline's stock price is currently 1,990.02 p, and its average 12-month price target is 2,044.55 p.
Hikma Pharmaceuticals's stock price is currently 1,272.00 p, and its average 12-month price target is 2,012.50 p.
HUTCHMED (China) 's stock price is currently 219.00 p, and its average 12-month price target is 292.52 p.
Dechra Pharmaceuticals's stock price is currently N/A, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline does not currently pay dividends.
Hikma Pharmaceuticals currently pays a dividend of 36.09 p which represents an annual dividend yield of 4.93%. Hikma Pharmaceuticals's next Ex-dividend date is March 19, 2026 and its next payout date is April 30, 2026.
HUTCHMED (China) does not currently pay dividends.
Dechra Pharmaceuticals does not currently pay dividends.